Fig. 5
From: miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer
Expression of ALDH1A3 in 32 normal control and 100 breast cancer patients’ plasma. a, b Expression of ALDH1A3 significant elevated in breast cancer plasma (p < 0.0001), especially in TNBC. c, d ALDH1A3 significantly upregulated in breast cancer cases with higher histological grade (grade 3) (p = 0.0355) and more advanced disease stage (stage II, III, IV) (p = 0.0368). (*P ≤ 0.05, **P ≤ 0.01)